Skip to main content
  • Poster presentation
  • Open access
  • Published:

The use of colchicine in PFAPA syndrome, the french experience and literature review

Introduction

Background: PFAPA syndrome is the most frequent periodic fever syndrome in non-Mediterranean patients. The cause remains obscure but overexpression of inflammasome-related genes and increase IL-1b during attacks suggest an autoinflammatory mechanism. We wondered whether colchicine could be used as effective prophylactic treatment in PFAPA syndrome.

Objectives

To compare 2 groups of PFAPA patients distinguished by their response to colchicine prophylaxis, and to identify the predictive factors of response to this treatment.

Methods

We performed a retrospective, multicentric, chart review of PFAPA patients under colchicine prophylaxis. We distinguished one responder group, defined as patients, who had no more, or twice fewer crises under colchicine and another one of non-responders. Subgroup analyses were performed using the nonparametric Mann-Whitney test for the quantitative data and calculating the odds ratio and confidence interval for qualitative data. The difference between the two groups was considered significant for p value <0.05 or a confidence interval different from 1.

Results

Twenty children, 65% of boys, were studied. Their mean age at disease onset was 2.3 ± 1.5 years. The mean duration of attacks was 3.2 ± 1.1 days (SD) (1 to 7 days) of strong fever (mean 39.9°C) with chills (30%), pharyngitis (85%), abdominal pain (75%), cervical adenitis (65%), asthenia (60%) and aphtous stomatitis (50%). Half of patients, 57% (8/14) were heterozygous in the MEFV gene. Nine patients were responders to colchicine. No significant differences were found between the two groups (responder and non-responder).

Conclusion

We observed a relatively high rate of response to colchicine; however our study could not sort out the predictive factors of this effect.

Disclosure of interest

None declared.

Author information

Authors and Affiliations

Authors

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dusser, P., Neven, B., Hengten, V. et al. The use of colchicine in PFAPA syndrome, the french experience and literature review. Pediatr Rheumatol 12 (Suppl 1), P238 (2014). https://doi.org/10.1186/1546-0096-12-S1-P238

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1546-0096-12-S1-P238

Keywords